The Latest Clinical Advances in Thrombocytopenia
dc.contributor.editor | ten Cate, Hugo | |
dc.contributor.editor | Lammle, Bernhard | |
dc.date.accessioned | 2022-02-24T10:34:03Z | |
dc.date.available | 2022-02-24T10:34:03Z | |
dc.date.issued | 2022 | |
dc.identifier | ONIX_20220224_9783036528052_16 | |
dc.identifier.uri | https://directory.doabooks.org/handle/20.500.12854/78718 | |
dc.description.abstract | Platelets are critical elements in the blood stream, supporting hemostasis (defense against bleeding), as well as performing even more complex tasks within networks of biological (immunity) and pathophysiological processes, such as cancer and ischemia/reperfusion injury. Changes in the number (and function) of platelets may have a substantial impact on any of these processes. The “simple” finding of a reduced platelet count (thrombocytopenia) has a history (origin) and a consequence (e.g., bleeding). This book brings together international experts to provide an up-to-date overview of the impact of thrombocytopenia from a clinical perspective. | |
dc.language | English | |
dc.subject.classification | thema EDItEUR::M Medicine and Nursing | en_US |
dc.subject.other | thrombotic thrombocytopenic purpura | |
dc.subject.other | depression | |
dc.subject.other | resilience | |
dc.subject.other | quality of life | |
dc.subject.other | inherited thrombocytopenias | |
dc.subject.other | platelets | |
dc.subject.other | bleeding | |
dc.subject.other | TTP | |
dc.subject.other | ADAMTS13 | |
dc.subject.other | treatment | |
dc.subject.other | diagnosis | |
dc.subject.other | follow-up | |
dc.subject.other | review | |
dc.subject.other | caplacizumab | |
dc.subject.other | pseudothrombocytopenia | |
dc.subject.other | hematimetry | |
dc.subject.other | fluorescence | |
dc.subject.other | amikacin | |
dc.subject.other | anticoagulants | |
dc.subject.other | COVID-19 | |
dc.subject.other | platelet | |
dc.subject.other | thrombocytopenia | |
dc.subject.other | cardiac surgery | |
dc.subject.other | inflammation | |
dc.subject.other | biological prosthesis | |
dc.subject.other | extracorporeal life support | |
dc.subject.other | heparin-induced thrombocytopenia (HIT) | |
dc.subject.other | new concepts | |
dc.subject.other | pathogenesis | |
dc.subject.other | management | |
dc.subject.other | immune PF4/heparin/antibody complexes | |
dc.subject.other | Bayesian diagnostic thinking | |
dc.subject.other | therapeutic plasma exchange | |
dc.subject.other | intravenous immunoglobulins (IVIG) | |
dc.subject.other | immune thrombocytopenia | |
dc.subject.other | platelet destruction | |
dc.subject.other | immune tolerance | |
dc.subject.other | megakaryocytes | |
dc.subject.other | ITP treatment | |
dc.subject.other | virus infection | |
dc.subject.other | thrombocytopathy | |
dc.subject.other | aggregation | |
dc.subject.other | HIV | |
dc.subject.other | SARS-CoV-2 | |
dc.subject.other | hantavirus | |
dc.subject.other | coronavirus | |
dc.subject.other | influenza | |
dc.subject.other | platelet disorders | |
dc.subject.other | procoagulant platelets | |
dc.subject.other | activation endpoints | |
dc.subject.other | myelodysplastic syndromes (MDS) | |
dc.subject.other | bone marrow failure (BMF) syndromes | |
dc.subject.other | aplastic anemia (AA) | |
dc.subject.other | next-generation sequencing (NGS) | |
dc.subject.other | platelet function tests | |
dc.subject.other | platelet count | |
dc.subject.other | flow cytometry | |
dc.subject.other | anticoagulation | |
dc.subject.other | antifibrinolytic | |
dc.subject.other | antiplatelet | |
dc.subject.other | cancer | |
dc.subject.other | thrombopoietin receptor agonist | |
dc.subject.other | tranexamic acid | |
dc.subject.other | advanced liver disease | |
dc.subject.other | bleeding risk | |
dc.subject.other | cirrhosis | |
dc.subject.other | hemostasis | |
dc.subject.other | thrombopoietin receptor agonists/mimetics | |
dc.subject.other | platelet transfusion guidelines | |
dc.subject.other | platelet transfusion alternatives | |
dc.subject.other | platelet additive solutions | |
dc.subject.other | platelet pathogen inactivation/reduction | |
dc.subject.other | cold stored platelet concentrates | |
dc.subject.other | n/a | |
dc.title | The Latest Clinical Advances in Thrombocytopenia | |
dc.type | book | |
oapen.identifier.doi | 10.3390/books978-3-0365-2805-2 | |
oapen.relation.isPublishedBy | 46cabcaa-dd94-4bfe-87b4-55023c1b36d0 | |
oapen.relation.isbn | 9783036528052 | |
oapen.relation.isbn | 9783036528045 | |
oapen.pages | 312 | |
oapen.place.publication | Basel |
Files in this item
Files | Size | Format | View |
---|---|---|---|
There are no files associated with this item. |